Effects of non-pharmacological and non-surgical interventions on health outcomes in systemic sclerosis: protocol for a living systematic review
暂无分享,去创建一个
Richard S. Henry | B. Thombs | M. Hudson | A. Benedetti | J. Boruff | C. Boström | L. Mouthon | Ankur Krishnan | S. Culos-Reed | L. Kwakkenbos | J. Welling | M. Sauve | Geneviève Guillot | Marie-Nicole Discepola | David M Leader | E. Yakes Jimenez | M. Mattsson | A. Carboni-Jiménez | Robyn K. Wojeck | Joep Welling
[1] Analysis of Clinical Trials , 2020, Biostatistics Decoded.
[2] Richard S. Henry,et al. Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients , 2020, Journal of psychosomatic research.
[3] N. Smania,et al. Effect of a tailored home‐based exercise program in patients with systemic sclerosis: A randomized controlled trial , 2020, Scandinavian journal of medicine & science in sports.
[4] B. Thombs,et al. Protocol for a partially nested randomized controlled trial to evaluate the effectiveness of the Scleroderma Patient-centered Intervention Network Support Group Leader EDucation (SPIN-SSLED) Program , 2019, Trials.
[5] Natalie S Blencowe,et al. RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.
[6] J. Pauling,et al. The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: A systematic literature review. , 2019, Seminars in arthritis and rheumatism.
[7] J. D. de Vries-Bouwstra,et al. The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review , 2019, Rheumatology advances in practice.
[8] G. Rocco,et al. A comparison between two educational methods in the rehabilitation of the microstomia in systemic sclerosis: a randomized controlled trial , 2019, Clinical rehabilitation.
[9] J. Poole,et al. Randomized Controlled Trial to Evaluate an Internet‐Based Self‐Management Program in Systemic Sclerosis , 2019, Arthritis care & research.
[10] P. Cuijpers. The Challenges of Improving Treatments for Depression. , 2018, JAMA.
[11] J. D. de Vries-Bouwstra,et al. Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference , 2018, Clinical Rheumatology.
[12] I. Boutron,et al. Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial , 2017, Arthritis care & research.
[13] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.
[14] J. McGowan,et al. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. , 2016, Journal of clinical epidemiology.
[15] J. Poole,et al. Effectiveness of Nonpharmacologic Interventions in Systemic Sclerosis: A Systematic Review , 2015, Arthritis care & research.
[16] B. Levis,et al. Psychosocial Aspects of Scleroderma. , 2015, Rheumatic diseases clinics of North America.
[17] B. Thombs,et al. Major Depression Diagnoses Among Patients With Systemic Sclerosis: Baseline and One‐Month Followup , 2015, Arthritis care & research.
[18] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.
[19] J. Wyatt,et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide , 2014, BMJ : British Medical Journal.
[20] B. Levis,et al. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients. , 2013, Rheumatology.
[21] B. Thombs,et al. Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus. , 2013, Rheumatology.
[22] Ami A. Shah,et al. Race and Association With Disease Manifestations and Mortality in Scleroderma , 2013, Medicine.
[23] B. Thombs,et al. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. , 2011, Rheumatology.
[24] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[25] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.
[26] R. Steele,et al. Health-related quality of life in systemic sclerosis: a systematic review. , 2009, Arthritis and rheumatism.
[27] B. Thombs,et al. Depression in patients with systemic sclerosis: a systematic review of the evidence. , 2007, Arthritis and rheumatism.
[28] J. Haythornthwaite,et al. Psychologic factors in scleroderma. , 2003, Rheumatic diseases clinics of North America.
[29] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[30] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[31] L. Hedges. Estimation of effect size from a series of independent experiments. , 1982 .
[32] B. Levis,et al. Psychosocial issues and care for patients with systemic sclerosis , 2017 .
[33] M. Mayes. Systemic Sclerosis A. Clinical Features , 2007 .